Document Detail


Angiocentric T-cell lymphoma presenting as midface destructive lesion: case report and literature review.
MedLine Citation:
PMID:  12324793     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A case of angiocentric T-cell lymphoma presenting as a midface destructive lesion is reported. Angiocentric T-cell lymphoma typically manifests as an aggressive, progressively destructive, and necrotizing disorder, often with a fatal outcome. This case was characterized microscopically by the presence of an atypical lymphoid population that expressed a CD45+, CD3+ cytoplasmic, CD5+, and CD56- T-cell phenotype within a background of a polymorphous inflammatory infiltrate. Because of the rarity of the disorder, the differential diagnosis is discussed. Recent advances in clinical immunodiagnostics, the variations in therapeutic modalities, and the prognosis of the disease as reported in the recent literature are reviewed.
Authors:
Wei Yung Yih; Jeffery C B Stewart; F James Kratochvil; Monica B Zieper
Related Documents :
17199743 - Malt1, bcl10 and foxp1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
21965143 - Bilateral dysplasia epiphysealis hemimelica of the talus associated with a lower leg in...
15983693 - Pediatric myoepithelioma of the palate.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics     Volume:  94     ISSN:  1079-2104     ISO Abbreviation:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod     Publication Date:  2002 Sep 
Date Detail:
Created Date:  2002-09-26     Completed Date:  2002-12-17     Revised Date:  2006-04-24    
Medline Journal Info:
Nlm Unique ID:  9508562     Medline TA:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod     Country:  United States    
Other Details:
Languages:  eng     Pagination:  353-60     Citation Subset:  D; IM    
Affiliation:
Department of Pathology, Oregon Health & Science University, Portland, OR 97201, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Combined Chemotherapy Protocols / administration & dosage,  therapeutic use
Cyclophosphamide / administration & dosage
Doxorubicin / administration & dosage
Humans
Lymphoma, T-Cell, Peripheral / drug therapy,  pathology*,  radiotherapy
Male
Maxillary Sinus Neoplasms / drug therapy,  pathology*,  radiotherapy
Middle Aged
Nose Neoplasms / drug therapy,  pathology*,  radiotherapy,  surgery
Palatal Neoplasms / drug therapy,  pathology*,  radiotherapy
Palatal Obturators
Prednisone / administration & dosage
Radiotherapy, Adjuvant
Vincristine / administration & dosage
Chemical
Reg. No./Substance:
0/CHOP protocol; 23214-92-8/Doxorubicin; 50-18-0/Cyclophosphamide; 53-03-2/Prednisone; 57-22-7/Vincristine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Juvenile xanthogranuloma of the oral cavity in children: a clinicopathologic study.
Next Document:  Cytotoxicity of resin-based restorative materials on human pulp cell cultures.